Gland Pharma Q1 Review - Supply Constraints Play Spoilsport; Margins Remain Resilient: Nirmal Bang
2 weeks ago•Bloomberg Quint
Easing of supply chain constraints may soothe Gland Pharma’s pain
2 weeks ago•Livemint
Gland Pharma faces a revenue growth hurdle in FY23; stock falls
2 weeks ago•Business Standard
Volumes spurt at Gland Pharma Ltd counter
2 weeks ago•Business Standard
Gland Pharma Ltd leads losers in ‘A’ group
2 weeks ago•Business Standard
Gland Pharma shares hit 52-week low. Buy, sell or hold post Q1 results?
2 weeks ago•Livemint
Gland Pharma at fresh 52-week low as Q1 marred by multiple headwinds
2 weeks ago•Livemint
Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa
Current price is more than the intrinsic value